NASDAQ: NSYSNortech Systems Inc Stock
$9.25+1.00 (+12.12%)
Updated Apr 29, 2025
NSYS Price
$9.25
Fair Value Price
N/A
Market Cap
$25.54M
52 Week Low
$7.25
52 Week High
$17.89
P/E
-19.68x
P/B
0.75x
P/S
0.22x
PEG
N/A
Dividend Yield
N/A
Revenue
$128.13M
Earnings
-$1.30M
Gross Margin
13.1%
Operating Margin
-0.15%
Profit Margin
-1%
Debt to Equity
1.13
Operating Cash Flow
-$2M
Beta
0.37
Next Earnings
May 12, 2025
Ex-Dividend
N/A
Next Dividend
N/A
NSYS Overview
Nortech Systems Incorporated provides design and manufacturing solutions for electromedical devices, electromechanical systems, assemblies, and components in the United States, Mexico, and China. It offers a range of technical and manufacturing, and support services, including project management, designing, testing, prototyping, manufacturing, supply chain management, and post-market services. The company also provides manufacturing and engineering services for medical devices, printed circuit board assemblies, wire and cable assemblies, and higher-level electromechanical assemblies. In addition, it offers engineering and repair services. The company serves original equipment manufacturers in the aerospace and defense, medical, and industrial markets through business development teams and independent manufacturers' representatives. Nortech Systems Incorporated was founded in 1990 and is headquartered in Maple Grove, Minnesota.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine NSYS's potential to beat the market
- NSYS doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical Device
Industry Rating
C
NSYS
RankedUnranked of 107
RankedUnranked of 107
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $7.56 | A | |
| $22.55 | A | |
| $14.22 | A |
Be the first to know about important NSYS news, forecast changes, insider trades & much more!
NSYS News
Overview
Due Diligence Score
–
Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how NSYS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
NSYS is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
NSYS is good value based on its book value relative to its share price (0.75x), compared to the US Medical Devices industry average (3.95x)
P/B vs Industry Valuation
NSYS is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more NSYS due diligence checks available for Premium users.
Valuation
NSYS fair value
Fair Value of NSYS stock based on Discounted Cash Flow (DCF)
Price
$9.25
Fair Value
$12.02
Undervalued by
23.07%
NSYS is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
NSYS price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-19.68x
Industry
37.36x
Market
29.19x
NSYS price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.75x
Industry
3.95x
NSYS is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
NSYS's financial health
Profit margin
Revenue
$28.6M
Net Income
-$1.5M
Profit Margin
-5.2%
NSYS's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
NSYS's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$72.4M
Liabilities
$38.4M
Debt to equity
1.13
NSYS's short-term assets ($55.32M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NSYS's short-term assets ($55.32M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NSYS's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
NSYS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$793.0k
Investing
-$292.0k
Financing
-$796.0k
NSYS's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
NSYS vs Medical Device Stocks
Nortech Systems Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.